STipe Therapeutics
DenmarkEntry
2019
Hold
7yr
Status
Active
Who owns STipe Therapeutics?
STipe Therapeutics is currently owned by Wellington Partners through Wellington Partners Life Sciences (1998 vintage), since 2019. Across its history, STipe Therapeutics has been through 2 private equity ownership periods, detailed in the timeline below.
Hand-verified · updated 2026-08-10
Most recent investor
Wellington PartnersWellington Partners Life Sciences · 1998 · VC
2 ownership periods · full history below
Key facts
HQDenmark
SectorBiotech
StatusActive
Ownership history
2 ownership periods · co-invest detected
Active
Co-invest · 2 holders · 2019 · present
Wellington PartnersActive
2019 · present(7yr) · Wellington Partners Life Sciences · 1998 · VC
Sunstone Life Science VenturesExited 2024
2019 · 2024(5yr) · Sunstone Life Science Ventures IV · 2015 · VC
MOIC
–
More from Wellington Partners Life Sciences
Other portfolio companies in the same fund.
US
Switzerland
Germany
AustriaMore PE-backed in Biotech
Comparable biotech deals from other GPs.
Track STipe Therapeutics
Save this record to your watchlist and pick up your research where you left off. No spam.
Who could buy STipe Therapeutics?
7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.
Find likely buyersGet the full record on STipe Therapeutics.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue